Synergistic Effect of the Novel Mutations in Scn5a and Snta1 on Late Ina Contributing to LQT Syndrome

Heart - United Kingdom
doi 10.1136/heartjnl-2012-302920a.211
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

SCN5A Mutations and the Role of Genetic Background in the Pathophysiology of Brugada Syndrome

Circulation: Cardiovascular Genetics
2009English

KCNJ2 Mutations in Arrhythmia Patients Referred for LQT Testing: A Mutation T305A With Novel Effect on Rectification Properties

Heart Rhythm
Cardiovascular MedicinePhysiologyCardiology
2007English

A Novel Mechanism for the Treatment of Angina, Arrhythmias, and Diastolic Dysfunction: Inhibition of Late INa Using Ranolazine

Journal of Cardiovascular Pharmacology
Cardiovascular MedicinePharmacologyCardiology
2009English

Characterization of Mutations Contributing to Sulfathiazole Resistance in Escherichia Coli

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1998English

Gray Platelet Syndrome: Novel Mutations of the NBEAL2 Gene

American Journal of Hematology
Hematology
2017English

Novel GRN Mutations in Patients With Corticobasal Syndrome

Scientific Reports
Multidisciplinary
2016English

Novel and Heteroplasmic Mutations in Mitochondrial tRNA Genes in Brugada Syndrome

Cardiology Journal
MedicineCardiovascular MedicineCardiology
2018English

In Silico Assessment of Y1795C and Y1795H SCN5A Mutations: Implication for Inherited Arrhythmogenic Syndromes

American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular MedicinePhysiologyCardiology
2007English

Pilsicainide Administration Unmasks a Phenotype of Brugada Syndrome in a Patient With Overlap Syndrome Due to the E1784K SCN5A Mutation

Internal Medicine
Internal MedicineMedicine
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy